Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human cell receptors: potential drug targets to combat COVID-19
Pawan Kumar Raghav, Keerthana Kalyanaraman, Dinesh Kumar
Amino Acids (2021) Vol. 53, Iss. 6, pp. 813-842
Open Access | Times Cited: 25

Showing 25 citing articles:

A perspective on the applications of furin inhibitors for the treatment of SARS-CoV-2
Kasi Pandima Devi, Mahmoud Reza Pourkarim, Marijn Thijssen, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 2, pp. 425-430
Open Access | Times Cited: 26
Autoimmunity and Immunodeficiency in Severe SARS-CoV-2 Infection and Prolonged COVID-19
Jenny Garmendia, Alexis García, Claudia Valentina De Sanctis, et al.
Current Issues in Molecular Biology (2022) Vol. 45, Iss. 1, pp. 33-50
Open Access | Times Cited: 26
COVID-19 disease and malignant cancers: The impact for the furin gene expression in susceptibility to SARS-CoV-2
Dabing Li, Xiaoyan Liu, Lianmei Zhang, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 14, pp. 3954-3967
Open Access | Times Cited: 31
Pannexin-1 channel opening is critical for COVID-19 pathogenesis
Ross H. Luu, Silvana Valdebenito, Eliana Scemes, et al.
iScience (2021) Vol. 24, Iss. 12, pp. 103478-103478
Open Access | Times Cited: 30
Potential treatments of COVID-19: Drug repurposing and therapeutic interventions
Pawan Kumar Raghav, Zoya Mann, Simran Kaur Ahluwalia, et al.
Journal of Pharmacological Sciences (2023) Vol. 152, Iss. 1, pp. 1-21
Open Access | Times Cited: 11
COVID-19, Cation Dysmetabolism, Sialic Acid, CD147, ACE2, Viroporins, Hepcidin and Ferroptosis: A Possible Unifying Hypothesis
Attilio Cavezzi, Roberto Menicagli, Emidio Troiani, et al.
F1000Research (2022) Vol. 11, pp. 102-102
Open Access | Times Cited: 18
Experimental and clinical data analysis for identification of COVID-19 resistant ACE2 mutations
Pawan Kumar Raghav, Aditya Raghav, Anjali Lathwal, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
OM-85 Broncho-Vaxom®, a Bacterial Lysate, Reduces SARS-CoV-2 Binding Proteins on Human Bronchial Epithelial Cells
Lei Fang, Liang Zhou, Michael Tamm, et al.
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1544-1544
Open Access | Times Cited: 17
COVID-19 signalome: Potential therapeutic interventions
Kenneth Lundström, Altijana Hromić‐Jahjefendić, Esma Bilajac, et al.
Cellular Signalling (2022) Vol. 103, pp. 110559-110559
Open Access | Times Cited: 11
In vitro inhibition of SARS-CoV-2 Infection by dry algae powders
Daniel Garcia-Ruiz, Erendira Villalobos-Sánchez, David Alam-Escamilla, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Characterization of the angiotensin-converting enzyme 2 (ACE2), the main receptor for the SARS-CoV-2 virus.
Giti Jami, Mehrnaz Ataee, Vahide Esmaeili, et al.
PubMed (2023) Vol. 12, Iss. 3, pp. 24-44
Closed Access | Times Cited: 5
Targets of SARS-CoV-2: therapeutic implications for COVID-19
Rajni Chadha, Aditya Raghav, Basudha Banerjee, et al.
Elsevier eBooks (2024), pp. 3-14
Closed Access | Times Cited: 1
Computational approaches for hematopoietic stem cells
Pawan Kumar Raghav, Basudha Banerjee, Rajesh Kumar, et al.
Elsevier eBooks (2024), pp. 331-346
Closed Access | Times Cited: 1
Blood pH Analysis in Combination with Molecular Medical Tools in Relation to COVID-19 Symptoms
Hans‐Christian Siebert, Thomas Eckert, Anirban Bhunia, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1421-1421
Open Access | Times Cited: 3
Nanoscale Technologies in the Fight against COVID-19: From Innovative Nanomaterials to Computer-Aided Discovery of Potential Antiviral Plant-Derived Drugs
Nunzio Iraci, Carmelo Corsaro, Salvatore V. Giofrè, et al.
Biomolecules (2022) Vol. 12, Iss. 8, pp. 1060-1060
Open Access | Times Cited: 4
COVID-19, liver dysfunction and pathophysiology: A conceptual discussion
Jucier Gonçalves Júnior
World Journal of Gastroenterology (2022) Vol. 28, Iss. 6, pp. 683-688
Open Access | Times Cited: 3
Clinical investigation of COVID-19 prevention and treatment
Shweta Kulshrestha, Aditya Raghav, Rajni Chadha, et al.
Elsevier eBooks (2024), pp. 127-137
Closed Access
Comparative clinical investigation of blood profiling in COVID-19 patients
Shweta Kulshrestha, Aditya Raghav, Rajni Chadha, et al.
Elsevier eBooks (2024), pp. 29-43
Closed Access
Experimental and analytical pipeline for sub-genomic RNA landscape of coronavirus by Nanopore sequencer
Bo-Jia Chen, Ching‐Hung Lin, Hung‐Yi Wu, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 4
Open Access
Predicting susceptibility to COVID-19 infection in patients on maintenance hemodialysis by cross-coupling soluble ACE2 concentration with lymphocyte count: an algorithmic approach
Shuang Yuan, Fulei Meng, Shuai Zhou, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Artificial Intelligence in the Management of Human Resources and Psychology
Fatma Köprülü, Stephen Ofori Yeboah, Behçet Öznaçar, et al.
(2024) Vol. 6, Iss. 4, pp. 354-359
Open Access
Peptides with antiviral activities
Anjali Jayasree Balakrishnan, Aswathi Kodenchery Somasundaran, Prajit Janardhanan, et al.
Elsevier eBooks (2023), pp. 219-235
Closed Access | Times Cited: 1
Human Cell Receptors and Downstream Cascades: A Review of Molecular Aspects and Potential Therapeutic Targets in COVID-19
Shervin Afzali, Mohammadvala AshtarNakhaei, Sara Shiari, et al.
Archives of Pediatric Infectious Diseases (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 1
The Surging Mechanistic Role of Angiotensin Converting Enzyme 2 in Human Pathologies: A Potential Approach for Herbal Therapeutics
Priyadarshini Gupta, Vibha Rani
Current Drug Targets (2023) Vol. 24, Iss. 13, pp. 1046-1054
Closed Access
Identifying featured indels associated with SARS-CoV-2 fitness
Xiang Li, Hongliang Yan, Gary Wong, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 5
Open Access
Page 1

Scroll to top